A group of parents in The Gambia have begun legal action against the government, an Indian pharmaceutical company and a medicine importer followings the deaths of their children which have been linked to cough syrup manufactured in India.
The 19 parents are seeking about $4.7m (£3.7m) in damages.
A team of lawyers from the Gambia Bar Association and the Female Lawyers Association of The Gambia are representing the parents.
They want the health ministry and the medicines control agency to admit they failed in their duties to regulate the importation, distribution, and sale of medicines in the country.
They are also asking for a declaration that their children did in fact die from the cough syrup and want the importer’s license to be withdrawn.
